Feel Better. Live Stronger.

SEMAGLUTIDE-TREATMENT

Semaglutide

Semaglutide is a groundbreaking medication designed to support individuals in their weight loss journey by effectively reducing appetite and enhancing feelings of fullness. This innovative treatment mimics the action of the natural hormone GLP-1, which plays a crucial role in regulating hunger and food intake. By influencing these pathways, semaglutide helps you take control of your eating habits, leading to consistent and sustainable weight loss. Studies have shown that patients using semaglutide can achieve an average weight loss of approximately 15% of their body weight, making it one of the most effective non-surgical weight loss options available.

In addition to significant weight loss, semaglutide offers several other health benefits. It can help improve conditions often associated with obesity, such as high blood pressure, type 2 diabetes, and elevated cholesterol levels. The medication is administered as a simple, once-weekly injection, making it convenient and easy to integrate into your lifestyle. The dosing is carefully titrated over time to minimize potential side effects, ensuring a comfortable and manageable experience. Semaglutide represents a powerful tool in the fight against obesity, offering a safe and effective solution for long-term weight management.

SEMAGLUTIDE plan

Phase 1
$579
12 week Plan
Phase 2
$359/mo*
AFTER 12 weeks

* ($339/mo if billed every three months)

This weight loss plan is ideal for the patient who does not need hormone replacement therapy but requires pharmacologic treatment to help reach desired weight loss goals. The consultation is no cost, no obligation. If determined to be a candidate for medical weight loss therapy, there are 2 phases of care. (Phase 1) all semaglutide patients start off on a 12-week regimen at the initial recommended dosage by your provider. (Phase 2) you are billed monthly. You also have the ability to be billed every three months at a discount. Most patients start out at a low dose and work up to a higher, more effective dose. This is typically done over a 4–6-month period.

Tirzepatide

Tirzepatide is an innovative medication that targets weight management by combining the effects of two hormones, GLP-1 and GIP, which are involved in regulating appetite and glucose metabolism. By activating these dual pathways, tirzepatide enhances the body’s ability to control hunger, leading to more effective and sustained weight loss. Clinical trials have demonstrated that patients using tirzepatide can achieve significant weight reduction, with some studies reporting average weight loss of up to 20% of body weight. This makes tirzepatide a potent option for those seeking to manage their weight, especially for individuals who may not have had success with other treatments.

When comparing tirzepatide to semaglutide, both medications offer substantial benefits for weight loss, but they work slightly differently. While semaglutide focuses on the GLP-1 pathway to reduce appetite, tirzepatide’s dual action on both GLP-1 and GIP receptors provides an additional mechanism to enhance weight loss. This dual action may lead to greater weight loss in some patients and potentially offer additional metabolic benefits. Like semaglutide, tirzepatide is administered via a once-weekly injection, and its dosing is also titrated to minimize side effects. However, the choice between the two may depend on individual health needs and response to treatment, with tirzepatide emerging as a strong contender for those needing a more aggressive approach to weight management.

ORAL SEMAGLUTIDE

Tirzepatide Plan

Phase 1
$879
12 week Plan
Phase 2
$629/mo*
AFTER 12 weeks

* ($609/mo if billed every three months)

The weight loss plan is ideal for the patient who does not need hormone replacement therapy but requires pharmacologic treatment to help reach desired weight loss goals. The consultation is no cost, no obligation. If determined to be a candidate for medical weight loss therapy, there are 2 phases of care. (Phase 1) all Tirzepatide patients start off on a 12-week regimen at the initial recommended dosage by your provider. (Phase 2) you are billed monthly. You also have the ability to be billed every three months at a discount. Most patients start out at a low dose and work up to a higher, more effective dose. This is typically done over a 4–6-month period.

How Our Services Work

Schedule
Free consultation

  • No cost, no obligation!
  • Same day consult available!

Weight loss
consultation

  • Telemedicine visit with licensed medical provider on your time.
  • Discuss your health concerns, options for weight loss, dietary supplements and exercise recommendations.

Begin
Treatment

  • If approved for weight loss your prescription will be shipped directly to your home with supplies
  • Access your personalized patient portal to communicate with your providers and attend follow up visits

Frequently Asked Questions

Semaglutide is the active ingredient found in the brand-name medications Wegovy® and Ozempic®. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed as an adjunct to a healthy diet and exercise regimen for weight loss and management.

While every individual responds differently to medications, a medical study of 1961 participants demonstrated that in a 68-week period, participants lost an average body weight of ~15%. Furthermore, 1 out of 3 participants lost more than 20% of their baseline body weight.